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Abstract
Background: Notch signaling is highly conserved in the metazoa and is critical for many cell fate
decisions. Notch activation occurs following ligand binding to Notch extracellular domain. In vitro
binding assays have identified epidermal growth factor (EGF) repeats 11 and 12 as the ligand binding
domain of Drosophila Notch. Here we show that an internal deletion in mouse Notch1 of EGF
repeats 8–12, including the putative ligand binding domain (lbd), is an inactivating mutation in vivo.
We also show that maternal and zygotic Notch1lbd/lbd mutant embryos develop through gastrulation
to mid-gestation.
Results:  Notch1lbd/lbd embryos died at mid-gestation with a phenotype indistinguishable from
Notch1 null mutants. In embryonic stem (ES) cells, Notch1lbd was expressed on the cell surface at
levels equivalent to wild type Notch1, but Delta1 binding was reduced to the same level as in
Notch1 null cells. In an ES cell co-culture assay, Notch signaling induced by Jagged1 or Delta1 was
reduced to a similar level in Notch1lbdand Notch1 null cells. However, the Notch1lbd/lbd allele was
expressed similarly to wild type Notch1 in Notch1lbd/lbd ES cells and embryos at E8.75, indicating that
Notch1 signaling is not essential for the Notch1 gene to be expressed. In addition, maternal and
zygotic Notch1 mutant blastocysts developed through gastrulation.
Conclusion: Mouse Notch1 lacking the ligand binding domain is expressed at the cell surface but
does not signal in response to the canonical Notch ligands Delta1 and Jagged1. Homozygous
Notch1lbd/lbd mutant embryos die at ~E10 similar to Notch1  null embryos. While Notch1 is
expressed in oocytes and blastocysts, Notch1 signaling via canonical ligands is dispensable during
oogenesis, blastogenesis, implantation and gastrulation.
Background
Notch1 is a heterodimeric, type I transmembrane receptor
that is required for cell fate decisions throughout the
metazoa [1,2]. The Notch1 extracellular domain contains
36 tandem epidermal growth factor-like (EGF) repeats,
and three Lin/Notch repeats. Of the 36 EGF repeats in
Drosophila Notch, deletion of only EGF repeats 11 and 12
prohibits the binding of the Notch ligands Delta and Ser-
rate in in vitro binding assays [3,4]. Notch signaling in
mammals is also initiated by binding to canonical Notch
ligands (Delta and Jagged) on adjacent cells. Ligand bind-
ing activates Notch signaling through two proteolytic
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cleavage events, first in the extracellular domain by the
ADAM10 metalloprotease [5], and subsequently in the
transmembrane domain by a presenilin complex with γ-
secretase activity [6,7]. The released Notch intracellular
domain (NICD) translocates to the nucleus and binds to
the CSL (CBF1, Suppressor of hairless, Lag-1) transcrip-
tional repressor [6]. The NICD/CSL complex recruits co-
activators including mastermind (MAML), and up-regu-
lates a number of target genes including the HES (Hairy/
Enhancer of Split) family of basic helix-loop-helix tran-
scriptional regulators.
The Notch1 gene has been inactivated in mice by inserting
a neomycin gene into EGF32 (Notch1in32; [8]) or by delet-
ing a large internal fragment from aa 1056–2049 that
spans the transmembrane domain (Notch1tm1/Con/1; [9]).
The Notch1in32 mutation generates a null allele [10] and
Notch1tm1/Con/1  homozygotes have an indistinguishable
embryonic lethal phenotype. Notch1 null embryos die at
mid-gestation around E10, with severe defects in somi-
togenesis, neurogenesis, vasculogenesis and cardiogen-
esis. The phenotype of flies expressing Notch with the
ligand binding domain deletion is not known. Thus in
order to investigate biological consequences of this type
of Notch mutation, we generated a mouse Notch1 muta-
tion termed Notch1lbd by deleting EGF repeats 8–12 (aa
290–481), which include the putative Notch1 ligand
binding domain. We show that Notch1lbd is expressed on
the cell surface but cannot bind to canonical Notch lig-
ands nor signal in response to these ligands. Homozygous
Notch1lbd/lbd embryos exhibit defects during embryogene-
sis similar to Notch1 null mutants. However, Notch1lbd
transcripts are expressed at levels similar to wild type in ES
cells and in E8.75 Notch1lbd/lbd embryos, indicating that
canonical Notch1 signaling is not essential for Notch1
gene expression during early embryogenesis. In addition,
while  Notch1  is expressed in oocytes and blastocysts
[11,12], we show that oocyte-specific inactivation of
Notch1 does not affect oogenesis or fertilization and that
maternal and zygotic mutants proceed normally through
blastogenesis, implantation and gastrulation.
Results
Notch signaling defects in Notch1lbd/lbd embryos
To generate mice with Notch1 lacking the putative ligand
binding domain, embryonic stem (ES) cells with loxP
sequences flanking exons 6 – 8 of mouse Notch1 were
generated by gene targeting (Fig. 1A; [13]). Exons 7 and 8
encode EGF11 and EGF12 and exon 6 was included in
order that the mutant Notch1 was ~20 kDa lower in
molecular weight. Two independent ES colonies selected
for resistance to G418 were shown by Southern analysis to
carry a targeted Notch1 allele (Fig. 1B). Chimeric mice car-
rying the mutant allele were crossed with mice expressing
the MeuCre40 recombinase transgene [14] to obtain mice
with a Notch1lbd allele after deletion of exons 6 – 8 along
with the HSVtk/Neo cassette (Fig. 1A). Southern blot and
PCR analysis of genomic DNA were used to genotype E9.5
embryos of Notch1+/lbd crosses (Fig. 1C). All expected gen-
otypes were represented at this stage. However, only wild
type and heterozygous pups were born from 6 litters
(Table 1).
To determine when Notch1lbd/lbd embryos die, embryos
from Notch1+/lbd crosses were examined during embryo-
genesis.  Notch1lbd/lbd  embryos were indistinguishable
from wild type at ~E8.75, but by ~E9.5 Notch1lbd/lbd
embryos were severely growth-retarded, with a tube-like
heart, distended pericardial sac, and defective vasculariza-
tion of the yolk sac (Fig. 1D). By ~E10.5, many mutant
embryos were resorbed and all mutant embryos were
resorbed by ~E11.5. Therefore Notch1lbd/lbd  embryos
exhibited global defects in Notch signaling with a pheno-
type indistinguishable from Notch1in32 [8] or Notch1tm1/
Con/1 [9] null embryos.
Notch1lbd is expressed at the cell surface but does not 
signal
Blastocysts from heterozygous Notch1+/lbd crosses were
used to isolate embryonic stem (ES) cell lines of each gen-
otype. Reverse transcription (RT)-PCR of total RNA
showed that Notch1lbd/lbd ES cells expressed Notch1 tran-
scripts at levels similar to wild type and heterozygous ES
cells (Fig. 1E). Notch1lbd/lbd ES cells had a similar growth
rate to Notch1+/lbd and Notch1+/+ ES cells (Fig. 2A). This
was also observed with Notch1 null ES cells [10]. An anti-
body to the extracellular domain of Notch1 (8G10)
detected the ~300 kD full length Notch1 in wild type ES
cells and the ~280 kDa truncated Notch1 in Notch1lbd/lbd
ES cells (Fig. 2B). The ~180 kDa Notch1 extracellular
domain was not routinely observed, but when present it
was in similar amounts in Notch1lbd/lbd and  Notch1+/
+cells. Flow cytometry showed that equivalent amounts of
wild type and mutant Notch1 receptors were present on
the surface of Notch1+/+ and Notch1lbd/lbd ES cells, respec-
tively (Fig. 2C). Therefore the internal deletion that
includes the putative ligand binding domain did not
affect Notch1 stability or trafficking to the cell surface.
Table 1: Progeny of the cross Notch1+/lbd X Notch1+/lbd.
No. Litters Pups/Embryos Stage Genotype
+/+ +/lbd lbd/lbd
63 5 P 1 0 1 2 2 3 0
64 4 E 9 . 5 1 2 2 1 1 1
Pups at postnatal day 10 (P10) were genotyped from litters of 5 
Notch1+/lbd females mated to 5 Notch1+/lbd males. Yolk sacs of E9.5 
embryos were genotyped following timed matings of 6 Notch1+/lbd 
females to 4 Notch1+/lbd males.BMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
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When Notch1 binds canonical Notch ligands, it under-
goes cleavage by γ-secretase and the new N-terminus of
activated Notch1 may be detected by the antibody
Val1744 [15]. Western blot analysis revealed a robust sig-
nal for activated Notch1 in cultured wild type ES cells but
no corresponding signal was observed in Notch1lbd/lbd ES
cells (Fig. 2B). Thus while Notch1lbd is expressed at the cell
surface it is not activated under conditions that activate
wild type Notch1, presumably because of the loss of its
ligand binding domain. Indeed the Notch ligand Delta1
had reduced binding to Notch1lbd/lbd ES cells (Fig. 2D). ES
cells express each of the four mammalian Notch receptors
and all would be expected to bind Delta1. To confirm that
the reduced binding of Delta1 to Notch1lbd/lbd is due to
the Notch1lbd mutation, we examined Delta1 binding to
Notch1 null ES cells (Notch1in32/in32) termed 290-2 which
lack Notch1 on the cell surface [10]. The binding of
Delta1 to 290-2 cells was reduced to the same extent as to
Notch1lbd/lbd cells (Fig. 2D). Therefore, the deletion of
EGF repeats 8–12 in mouse Notch1 eliminates Delta1
Targeting of the Notch1 gene Figure 1
Targeting of the Notch1 gene. (A) Schematic representation of the floxed region of the mouse Notch1 gene. Exons 6 – 8 (* 
designates a T466A point mutation termed Notch112f described by [13]) and the HSVTk/Neo cassette were removed by Cre 
recombinase to generate the Notch1lbd allele. The diagram of Notch1 ECD shows EGF repeats as rectangles and LIN repeats as 
ovals. The ligand binding domain in EGF repeats 11 and 12 is striped. Amino acids 290–481 were removed by the Notch1lbd 
mutation. PCR primers 5F, 6R and 9R and the P1415 probe are indicated. B1: BamHI; E1: EcoRI; H3: HindIII. (B) Southern blot 
analysis of two targeted ES clones (C32 and 132D) by hybridization with probe P1415 after digestion with HindIII or HindIII and 
EcoRI. (C) Southern blot analysis and PCR genotyping of yolk sac genomic DNA from E9.5 embryos from a Notch1+/lbd hetero-
zygous cross. Genomic DNA was digested with BamHI and probed with P1415. (D) RT-PCR analysis of total RNA from ES 
cells of the genotypes shown. A hybrid band was obtained from Notch1+/lbd cDNA. (E) E9.5 embryos exhibited defective vascu-
larization of yolk sac and retarded development of Notch1lbd/lbd embryos, but no apparent differences between wild type and 
heterozygous progeny.BMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
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binding to Notch1 as expected, but binding to other
Notch receptors remains. This residual binding was pre-
vented by including EDTA in the binding buffer under
conditions that prevent Notch/ligand binding but do not
release Notch receptors from the cell surface. Delta1-
induced Notch1 signaling was also reduced in Notch1lbd/
lbd ES cells as shown by a co-culture reporter assay which
detects signaling through all four Notch receptors (Fig.
2E). A second canonical Notch ligand, Jagged1, was also
defective at inducing Notch signaling in Notch1lbd/lbd ES
cells (Fig. 2E). Delta1- and Jagged1-induced Notch signal-
ing was also reduced, but not eliminated, in Notch1in32/
in32 ES cells which are Notch1 null [10] (Fig. 2E). Residual
Notch signaling presumably reflects the presence of the
other three Notch receptors.
Notch1 signaling is not essential for Notch1 gene 
expression in early embryogenesis
The Notch1lbd mutant allele is transcribed similarly to the
wild type allele in Notch1lbd/lbd ES cells (Fig. 1E) but
Notch1lbd/lbd ES cells are defective in Notch1 signaling
(Figs. 1 and 2). The Notch1lbd mutant allele therefore
Notch1 lacking the ligand binding domain is expressed on the cell surface but does not signal Figure 2
Notch1 lacking the ligand binding domain is expressed on the cell surface but does not signal. (A) Growth curves 
of ES cells isolated from E3.5 Notch1+/+, Notch1+/lbd and Notch1lbd/lbd blastocysts. Bars represent mean ± SD. (B) Western blot 
analysis of ES cell lysates (50 μg protein). Full length Notch1 was detected by antibody 8G10 and activated Notch1 was 
detected by antibody Val1744. Blots were stripped and reprobed using anti-β-Tubulin III. Data are representative of 3 experi-
ments. (C) Flow cytometry of cell surface Notch1 in Notch1lbd/lbd and Notch1+/+ ES cells using anti-Notch1 ECD antibody 8G10 
followed by Alexa-488 conjugated anti-hamster IgG. Grey profiles are secondary antibody alone. Profiles are representative of 
two experiments. (D) Notch ligand binding. ES cells were incubated with soluble Delta1-Fc followed by PE-conjugated anti-
human IgG and analyzed by flow cytometry. Notch1in32/in32 null ES cells were line 290-2. EDTA in the binding buffer inhibited 
binding to all Notch receptors. Bars represent mean ± SEM; n = 5 for Notch1+/+ and Notch1lbd/lbd; n = 3 for Notch1in32/in32 ES 
cells. (E) ES cells were assayed for Notch signaling after transfection of the Notch TP-1 reporter construct by co-culturing with 
L cells expressing Delta1 or Jagged1 compared to control L cells. Bars represent fold-activation ± SEM for Notch1+/+ (white), 
Notch1lbd/lbd and Notch1in32/in32 (gray) (n = 4; ** P < 0.01, *** P < 0.001).BMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
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allowed us to determine if signaling via Notch1  is
required for the Notch1  gene to be expressed in vivo.
Notch1+/lbd females were crossed with Notch1+/lbd males
and embryos were examined at mid-gestation. Notch1lbd/
lbd embryos were morphologically indistinguishable from
wild type embryos at E8.75 and were examined for
Notch1 gene expression by in situ hybridization. It can be
seen in Fig. 3A that Notch1 was expressed in the presom-
itic mesoderm (PSM) the forming somite (arrows) and
the neural tube. The hybridization signal obtained for
wild type and Notch1lbd/lbd embryos was similar. There-
fore expression of the Notch1  gene was not markedly
altered by the loss of canonical Notch1 signaling in early
embryogenesis. By contrast, following removal of Pofut1
[16] or Mind bomb 1 [17,18], both of which inhibit
Notch signaling through all four Notch receptors, Notch1
expression is reduced in the PSM and enhanced in neural
tube and mesencephalon of E8.75 embryos. At E9.0,
Notch1 transcripts were markedly reduced in Notch1lbd/
lbd embryos (Fig. 3B). By E9.5 when Notch1lbd/lbd embryos
were dying, Notch1 gene expression was severely reduced
(Fig. 3C).
Whole mount in situ hybridization provided additional
confirmation that the Notch1lbd  mutation inactivates
Notch1 signaling. The Notch1 target and somitogenic
genes Hes5, Myogenin and Uncx4.1 were examined in
embryos at E9.5. At that stage Hes5 is expressed in neural
Whole mount in situ hybridization of Notch1 pathway and somitogenic genes Figure 3
Whole mount in situ hybridization of Notch1 pathway and somitogenic genes. Control (Notch1+/+) embryos (left) 
and mutant Notch1lbd/lbd denoted lbd/lbd (right) embryos were probed together. Arrows point to highest expression. (A) 
Notch1 expression in E8.75 control and Notch1lbd/lbd embryos was similar (~9.7 kb probe). (B) At E9.0 Notch1 expression was 
reduced in Notch1lbd/lbd compared to control embryos (~4.7 kb probe). (C) At E9.5 Notch1 expression was barely detectable in 
Notch1lbd/lbd embryos (~9.7 kb probe). (D) Expression of the Notch target gene Hes5 was reduced in mutant embryos at E9.5, 
with residual expression in brain. (E) Myogenin was poorly and diffusely expressed in E9.5 Notch1lbd/lbd embryos. (F) Uncx4.1 was 
expressed in the caudal compartment of formed somites of control but was missing from the somitic region of E9.5 Notch1lbd/
lbd embryos. Uncx4.1 was up-regulated in the midbrain (asterisk) of E9.5 Notch1lbd/lbd embryos (n ≥ 3 for mutant embryos for 
each probe).BMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
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tube, brain and the forming and formed somites. The
Hes5 gene is a known target of Notch1 signaling and its
expression was severely reduced in Notch1lbd/lbd embryos
(Fig. 3D). Myogenin is expressed in mature somites of
wild type embryos at E9.5. In Notch1lbd/lbd  embryos
which had 13–17 (n = 3) poorly-formed somites, Myo-
genin expression was greatly reduced (Fig. 3E). The myo-
genic transcription factor Uncx4.1  is expressed on the
posterior side of mature somites and in the PSM of wild
type embryos at E9.5. In Notch1lbd/lbd embryos, expres-
sion in somites and PSM was lost (Fig. 3F). However,
expression of Uncx4.1  was induced in brain in the
absence of Notch1 signaling, as observed previously in
embryos defective in signaling through all four Notch
receptors [16]. We previously showed that cyclin D1
expression is markedly reduced in Notch1lbd/lbd embryos
[19]. Importantly therefore, the Notch1 signaling defects
observed in Notch1lbd/lbd embryos are not rescued by non-
canonical Notch1 ligands that might bind to the large por-
tion of the Notch1 extracellular domain that remains in
Notch1lbd.
Maternal and zygotic Notchllbd/lbd mutant blastocysts 
implant and develop through gastrulation
Following oocyte-specific deletion of Pofut1  or  RBP-Jκ
null oocytes are fertilized and mutant blastocysts develop
through gastrulation [20,21]. Pofut1 [16] and RBP-Jκ [22]
are essential for Notch signaling through all four Notch
receptors. Pofut1 transfers fucose to Notch receptors and
RBP-Jκ complexes with the cleaved ICD of all Notch
receptors, but both activities might have effects that are
independent of the Notch pathway. Thus it was of interest
to determine if Notch1lbd/lbd blastocysts could develop
and implant because Notch1 is expressed in oocytes, ferti-
lized eggs and blastocysts [11,12]. To obtain maternal and
zygotic mutant blastocysts, females homozygous for the
Notch1  floxed allele (Fig. 1A) and carrying a ZP3Cre
transgene were generated (Fig. 4A). Notch1F/F:ZP3Cre
females were mated with Notch1+/lbd or wild type males.
Pups and E9.5 embryos were genotyped (Table 2). At
birth, all pups from Notch1F/F:ZP3Cre by wild type crosses
were heterozygous showing that the Cre recombinase was
highly efficient since the Notch1F allele was not transmit-
ted. At E9.5, 29 embryos from 4 crosses included 15
mutants (Notch1lbd/lbd) and 14 heterozygotes (Notch1+/
lbd). Therefore, eggs with Notch1 lacking the ligand bind-
ing domain were fertilized by sperm that also lacked func-
tional Notch1 and gave the same number of E9.5 embryos
as eggs fertilized with a Notch1+ sperm.
Mutant embryos derived from Notch1lbd/lbd  eggs and
therefore lacking maternal and zygotic transcripts of func-
tional Notch1 were examined at E8.75 and E9.5. All
Notch1lbd/lbd E9.5 embryos were surrounded by a yolk sac
with defective vascularization (Figs. 4B, C). Notch1+/lbd
and Notch1lbd/lbd embryos at E8.75 (8 vs. 6 from 2 litters)
were morphologically indistinguishable (Figs. 4D, E). By
E9.5, the Notch1lbd/lbd embryos were significantly smaller
than controls, and the Notch1 null mutant phenotype was
readily apparent (Figs. 4F, G). All developmental defects
in Notch1lbd/lbd embryos arising from mutant blastocysts
with or without maternal Notch1 transcripts appeared
similar. In addition, mutant embryos were morphologi-
cally similar to controls at E8.75 (Fig. 4D, E). Therefore
Notch1 signaling induced by canonical Notch ligands is
not required for oogenesis, ovulation, fertilization or any
of the developmental steps involved in blastogenesis,
implantation or gastrulation.
Discussion
The  Notch1lbd mutation is a novel Notch1 inactivating
mutation that gives a null phenotype with a defective
Notch1 that is expressed at normal levels at the cell sur-
face. The Notch1 cleavage site mutant which is not effi-
ciently cleaved by γ-secretase and is defective in Notch1
signaling [15] may also be expressed at the cell surface but
this point has not been directly investigated. However,
treatment of T cells with inhibitors of γ-secretase causes an
accumulation of a membrane-bound Notch1 stable inter-
mediate [23]. In Notch1lbd, removal of aa 290–481 from
the Notch1 ECD does not inhibit Notch1 synthesis, traf-
ficking or stability at the plasma membrane. Nevertheless,
Notch1lbd exhibits reduced signaling through Delta1 and
Jagged1 to the same extent as Notch1 null ES cells in a co-
culture reporter assay. Moreover, the binding of Delta1 is
reduced to the same extent as in cells that lack Notch1
Table 2: Progeny of crosses N1F/F:ZP3Cre X N1+/+ and N1F/F:ZP3Cre X N1+/lbd.
Female Male No. Litters Pups/Embryos Stage Genotype
+/+ +/lbd lbd/lbd
N1F/F:ZP3Cre N1+/+ 74 2 P 1 0 0 4 2 0
N1+/F:ZP3Cre N1+/+ 6 40 P10 21 19 0
N1F/F:ZP3Cre N1+/lbd 31 0 P 1 0 0 1 0 0
N1F/F:ZP3Cre N1+/lbd 42 9 E 9 . 5 0 1 4 1 5
Pups at postnatal day 10 (P10) were genotyped from litters of 8 Notch1F/F:ZP3Cre or 5 Notch1+/F:ZP3Cre females mated to 6 Notch1+/+ or 2 Notch1+/
lbd males. Yolk sacs of E9.5 embryos were genotyped following timed matings of 4 Notch1F/F:ZP3Cre females to 3 Notch1+/lbd males. N1, Notch1BMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
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altogether. This is consistent with in vitro binding experi-
ments which identify EGF repeats 11 and 12 of Dro-
sophila Notch as necessary for canonical ligand binding in
vitro  [3,4]. However, the Drosophila Notch EGF11/12
deletion mutant has not been investigated for Notch sign-
aling abilities, either in co-culture assays or,in vivo in the
fly.
Notch1lbd/lbd embryos die at ~E10 with the same develop-
mental phenotype as embryos that lack Notch1 [8,9]. It is
of interest that, despite the cell surface expression of most
of the Notch1 extracellular domain in Notch1lbd, there
appear to be no non-canonical Notch ligands that rescue
mutant embryos at mid-gestation. Also of interest, is the
fact that heterozygotes develop similarly to wild type
mice, and thus Notch1lbd does not behave in a dominant
negative fashion even though it is expressed at the cell sur-
face in similar amounts to wild type Notch1. It will be of
interest to see if Notch1+/lbd heterozygotes exhibit the more
subtle Notch1 signaling defects observed in the inner ear
[24], and in cell competition experiments [25] with other
Notch1+/null heterozygotes.
Whole mount in situ hybridization showed that Notch1lbd/
lbd embryos exhibit markedly reduced expression of the
Notch1 target genes Hes5 and cyclin D1 [19] and the somi-
togenic genes Myogenin and Uncx4.1. Similar results were
observed in Notch1 null mutants [8,9]. However, at E8.75
Notch1 transcripts were expressed at similar levels in
mutant and wild type controls (Fig. 3A). Previous studies
have shown that removal of Notch1 delays somitogenesis
at the 3-5 somite stage around E8 showing that Notch1
signaling is active at this stage, even though there are no
apparent changes in size, overall appearance, neurogene-
sis or cell death at E8 [9]. The embryos in Fig. 3A show
that Notch1 gene expression in early embryogenesis is not
solely controled by Notch1 signaling. This conclusion can
also be drawn from the equivalent expression of Notch1
transcripts in Notch1lbd/lbd and Notch1+/+ ES cells (Fig. 1D).
However, by E9.0 Notch1lbd/lbd embryos had markedly less
Notch1 expression than controls (Fig. 2E). This may sug-
gest that Notch1 signaling and Notch1 gene expression
operate in a feedback loop at this stage as suggested from
results of overexpression of Notch1 ICD in T cells [26,27]
or C2C12 cells [28]. However, overexpression experi-
ments may induce abberrant regulation of the Notch1
Notch1lbd/lbd maternal and zygotic null embryos Figure 4
Notch1lbd/lbd maternal and zygotic null embryos. (A) PCR of genomic DNA using primers 5F and 6R (Fig. 1A), and 
ZP3Cre primers. N1F: Notch1 floxed allele; Cre: ZP3Cre transgene. (B) – (C) E9.5 yolk sac with embryos from crosses between 
Notch1F/F:ZP3Cre females and Notch1+/lbd males. (D) – (E) E8.75 Notch1+/lbd and Notch1lbd/lbd embryos. (F) – (G) E9.5 Notch1+/lbd 
and Notch1lbd/lbd embryos. Representative results from a total of 14 E8.75 embryos and 29 E9.5 embryos.BMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
Page 8 of 11
(page number not for citation purposes)
gene and it is difficult to distinguish direct from indirect
effects in vivo. Indirect effects on Notch1 gene expression
are seen in Pofut1 [16] and Mib1 [17,18] null embryos
defective in global signaling that exhibit increased Notch1
gene expression in the PSM, the forming somite and the
forebrain at ~E8.75, suggesting that Notch1 expression at
that stage is negatively regulated via signaling through
Notch2, Notch3 and/or Notch4. By E9.5, Notch1  gene
expression is inhibited in the absence of Pofut1 [16] or
Mind bomb 1 [17,18]. Notch1 activation is also inhibited
at E9.5 in embryos lacking RBP-Jκ [29].
The conditional Notch1 floxed allele allowed us to ask
whether canonical Notch1 signaling is required for the
generation of developmentally-competent eggs, or for fer-
tilization, pre-implantation development, implantation
or gastrulation. Previous experiments in which global
Notch signaling was eliminated by the removal of Pofut1
or RBP-Jκ in oocytes suggest that Notch signaling is not
required through any of the four mammalian Notch
receptors until after gastrulation [20,21]. However, Pofut1
transfers fucose to EGF repeats with a consensus sequence
that is found in a number of proteins including Notch lig-
ands and Cripto [30,31]. While the presence of fucose on
an EGF repeat is not required for the function of either
Notch ligands [32] or Cripto [33], biological roles for O-
fucose have only begun to be explored. In addition, recent
experiments have shown that Notch lacking O-fucose may
signal under certain circumstances [34,48]. Similarly,
Notch-independent functions of RBP-Jκ have been
described [35,36]. Finally, Notch1 is expressed in oocytes
during oogenesis [37] and in ovulated eggs and develop-
ing blastocysts [11,12], leading to the prediction that
Notch1 signaling must be important for pre-implantation
development [11,12]. Thus it was important to examine
this question directly. Our data clearly show that Notch1
signaling through canonical Notch ligands is in fact dis-
pensable for oogenesis, ovulation, fertilization, blast-
ogenesis, implantation and gastrulation (Fig. 4). They also
show that expressing an inactive Notch receptor at the cell
surface does not have an inhibitory effect on any of these
developmental processes. However, non-canonical
Notch1 signaling by a pathway yet to be discovered may
be active in Notch1lbd/lbd oocytes or blastocysts. The fact
that Notch1lbd is well-expressed at the cell surface but not
responsive to canonical Notch ligands means it may be
used to search for novel Notch1 signaling pathways that
may be active in pre-implantation development.
Conclusion
In summary, we have shown that deletion of the mouse
Notch1 ligand binding domain generates Notch1 of ~280
kDa that is well-expressed on the cell surface but cannot
bind Delta1 nor be activated by Delta1 or Jagged1 in a co-
culture signaling assay. Homozygous mutant embryos die
at mid-gestation with defects similar to Notch1  null
embryos. Oocyte-specific deletion of the ligand bindng
domain does not impair oogenesis or development of
maternal and zygotic embryos until after gastrulation.
Methods
Targeting of the Notch1 gene
To generate the Notch1 ligand binding domain deletion
mutation Notch1lbd, an 1.6 kb region of genomic DNA
containing exons 6 – 8 and two flanking sequences ~4.3
kb 5' (upstream) and ~2.9 kb 3' (downstream) were
obtained by PCR from genomic DNA of WW6 ES cells
[38] and cloned separately into pCR2.1 (T-vector, Invitro-
gen, Carlsbad, CA). A point mutation termed 12f was
introduced into exon 8 by changing Thr466 to Ala [13].
The integrity of the three inserts was confirmed by DNA
sequencing and they were subcloned between the three
loxP sites in the pFlox vector [39] using BamHI, SalI and
XhoI with HindIII, respectively (Fig. 1A). The targeting vec-
tor was linearized using PvuI (the PvuI site between XhoI
and HindIII in pFlox had been removed during subclon-
ing). After gel purification, the plasmid was electropo-
rated into WW6 ES cells using a Bio-Rad Gene Pulser (Bio-
Rad, Hercules, CA) at 400 V and 250 μF. Following selec-
tion with 250 μg/ml active G418 (Invitrogen, Carlsbad,
CA), resistant colonies were screened for homologous
recombination by PCR using Takara Ex Taq (Takara Mirus
Bio, Madison, WI) and primers N1ES-gF: 5'-GCTTC-
CCGCCTCCACTGTGCTATTGATGTTTG-3' from
upstream of the 5' insertion site and pFlx-382R: 5'-GTTC-
CTCTTGCTGAACCACACTGCTCGATATTG-3' from the
pFlox vector, and confirmed using primers pFlx-3521F: 5'-
CTGTGCCTTCTAGTTGCCAGCCATCTGTTG-3' from the
pFlox vector and DM142: 5'-CTGAAGCCTTCTCGGCAG-
GTGCATACGTAG-3' from downstream of the 3' inser-
tion. Two positive ES clones were further characterized by
Southern blot analysis after digestion by HindIII or Hin-
dIII and EcoRI. The probe P1415 is a genomic DNA frag-
ment obtained by PCR from exons 14 to 15 of Notch1
using primers N1-ex14F: 5'-GTACAAGTGACTGT-
GCCCCTGGGTG-3' and N1-ex15R: 5'- CTGTATATGGCA-
GAGGACAGTTGCACTTG-3' and was used to determine
integration into the endogenous Notch1 locus. Targeted
ES cells were microinjected into C57Bl/6 blastocysts to
obtain chimeric mice. Chimeras were crossed with trans-
genic mice carrying Cre recombinase under the control of
a weak CMV promoter termed MeuCre40 [14] to obtain
heterozygous floxed Notch1 (Notch1+/F) mice. Oocyte-
specific Notch1 deletion was obtained by crossing
Notch1+/F mice with transgenic mice carrying Cre recombi-
nase under the control of the ZP3 promoter (ZP3Cre) as
previously described [20,39]. The deletion mutation was
confirmed by Southern blot analysis after BamHI diges-
tion using probe P1415 downstream of the 3' insertion
site. Genotyping was performed from tail DNA or yolk sacBMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
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DNA using forward primer 5F: 5'-GTATGTATAT-
GGGACTTGTAGGCAG-3', and reverse primer 6R: 5'-
CTATGAGGGGTCACAGGACCAT-3' that generate a 363
bp product from the wild type Notch1 allele and a 466 bp
product from the floxed Notch1 allele, or primers 5F and
9R: 5'-CTTCATAACCTGTGGACGGGAG-3' that generate a
575 bp product from the Notch1 ligand binding domain
deletion allele. ZP3Cre transgenic mice were genotyped as
described [39].
Embryonic Stem Cell Isolation
Embryonic stem (ES) cell lines C1 (Notch1+/+), C2
(Notch1+/lbd) and A2 (Notch1lbd/lbd) were isolated from E3.5
blastocysts obtained from Notch+/lbd X Notch+/lbd crosses as
described [40] and genotyped by PCR from yolk sac DNA.
Other ES cell lines used were WW6 [38] (Notch1+/+), and
290-2 Notch1 null cells [10] termed Notch1in32/in32 and
kindly provided by Dr. G. D. Longmore. ES cells were rou-
tinely cultured on a STO SNL2 feeder cell layer [41] in ES
medium (Knockout-DMEM supplemented with 15% fetal
bovine serum; Gemini, West Sacramento, CA, 1 × non-
essential amino acids, 1 × L-glutamine, 1000 U/ml
ESGRO® (Chemicon, Temecula, CA), 50 μM  ί-mercap-
toethanol, 25 mM HEPES, penicillin (50 U/ml) and strep-
tomycin (50 μg/ml). All reagents were ES-qualified and
from SpecialtyMedia (Phillipsburg, NJ) except where
mentioned). To remove feeder cells, ES cells were pas-
saged on gelatinized plates for 2 – 3 generations at an 1:10
ratio. For growth curves, ES cells were plated on 24-well
plates at 5 × 104 cells per well and incubated at 37°C in an
incubater with 5% CO2. Cells from triplicate wells were
trypsinized and counted after 24, 48, 72 and 96 h using a
Z1 Coulter particle counter (Beckman Coulter, Fullerton,
CA). Cells from each well were counted 3 times.
RT-PCR Analysis
Total RNA was isolated from ES cells using TRIZOL® (Inv-
itrogen, Carlsbad, CA) followed by DNase I (Promega,
Madison, WI) digestion according to the manufacturer's
instructions. cDNA was prepared using the Takara RNA
PCR Kit ver 3.0 (Takara Mirus Bio, Madison, WI). RT-PCR
analysis was performed using Notch1 forward primer: 5'-
GCCCTTTGAGTCTTCATACATCTG-3' and reverse primer:
5'-GACATTGGAACTCATTGATCTTGT-3'. PCR products
(500 bp from Notch1lbd and 1076 bp from Notch1+) were
separated by agarose gel electrophoresis and visualized by
ethidium bromide staining. Gapdh was used as control
(forward: 5'-ACCACAGTCCATGCCATCAC-3'; reverse: 5'-
TCCACCACCCTGTTGCTGTA-3', product size: 452 bp).
Immunoblot Analysis
ES cells growing on gelatinized plates were washed with
PBS and lysed in RIPA buffer (Upstate, Lake Placid, NY)
containing the complete protease inhibitors 'cocktail'
(Roche, Basel, Switzerland). After incubation for 30 min
on ice, the lysate was microfuged and protein concentra-
tion of the supernate was determined by Bio-Rad Dc pro-
tein assay (Bio-Rad, Hercules, CA). Lysates were resolved
by 4–20% gradient SDS-PAGE, transferred to polyvinyld-
ifluoride (PVDF) membranes and probed with Notch1
ECD antibody 8G10 (1:500; Upstate, Lake Placid, NY) to
detect full length Notch1, or Notch1 antibody Val1744
(1:1000; Cell Signaling Technology, Beverly, MA) to
detect activated Notch1. Horseradish peroxidase (HRP)-
conjugated secondary antibodies were used to detect reac-
tive bands visualized using Enhanced Chemilumines-
cence Reagent (Amersham Pharmacia Biotech,
Piscataway, NJ). A β-Tubulin-III specific antibody (1:500;
Sigma, St. Louis, MO) was used for loading control.
Flow Cytometry
For cell surface Notch1 detection, ES cells growing on
gelatinized plates at 70–80% confluence were dissociated
using phosphate buffered saline (PBS) -based enzyme-free
dissociation solution (SpecialtyMedia, Lavellette, NJ) for
10 min at 37°C. After washing with 10 ml medium, 5 ×
105 ES cells were incubated with 1 μg anti-Notch1 anti-
body (8G10, Upstate, Lake Placid, NY) in 100 μl FACS
binding buffer (Hank's balanced salt solution (HBSS)
containing 3% BSA, 0.05% sodium azide, and 1 mM
Ca2+) for 1 h at 4°C in the dark, followed after washing
with 1 ml FACS binding buffer, by incubation with 1:100
Alexa488-conjugated anti-hamster IgG antibody (Invitro-
gen, Carlsbad, CA) in 100 μl FACS binding buffer. After
washing with 1 ml FACS binding buffer, the cells were sus-
pended into 400 μl FACS binding buffer. Dead cells were
excluded by staining with 7-AAD (BD Pharmingen, San
Diego, CA). Flow cytometry was performed on a FACS
Calibur flow cytometer (BD Biosciences, San Diego, CA).
Data files were analyzed using Flowjo software (Tree Star,
San Carlos, CA).
Notch Ligand Binding Assay
Soluble Notch ligand Delta1 with a human Fc tag (Delta1-
Fc) [42,43] was kindly provided by Dr. Gerry Weinmaster.
HEK-293T cells expressing Delta1-Fc were cultured in
αMEM (Invitrogen) containing 10% fetal bovine serum
(Gemini). At 70–80% confluence, the medium was
changed to 293 SFM II serum-free medium (Invitrogen)
and culturing was continued. After 3 days, conditioned
medium was collected, cellular debris removed by centrif-
ugation, and the supernatant stored at 4°C. The concen-
tration of ligand was determined by comparison with
known concentrations of human IgG antibody (Jackson
Immunoresearch, West Grove, PA) detected by chemilu-
minescence (Amersham Pharmacia Biotech, Piscataway,
NJ) after western blotting. For the binding assay, 70–80%
confluent ES cells were dissociated from plates using PBS-
based enzyme-free dissociation solution (SpecialtyMedia,
Lavellette, NJ) for 10 min at 37°C. After washing with 10BMC Developmental Biology 2008, 8:48 http://www.biomedcentral.com/1471-213X/8/48
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ml medium, the single cell suspension of ES cells (5 × 105
cells) was incubated with 2 μg/ml Delta1-Fc in binding
buffer (HBSS containing 3% BSA, 0.05% sodium azide,
and 1 mM Ca2+) for 1 h at 4°C, followed after washing by
incubation with 1:100 phycoerythrin (PE)-conjugated
anti-human Fc antibody (Jackson Immunoresearch, West
Grove, PA) for 30 min at 4°C. To inhibit Delta1 binding,
5 mM EDTA was added to the binding buffer. Flow cytom-
etry was performed on a FACS Calibur flow cytometer.
Ligand binding ability was determined by mean fluores-
cence intensity (MFI) of primary and secondary antibody
binding minus the MFI of secondary antibody binding
alone.
Co-culture Notch Signaling Assay
The co-culture Notch signaling assay was performed
essentially as previously described [20]. In brief, duplicate
cultures of ES cells (Notch1+/+,(C1) and Notch1lbd/lbd (A2))
on 6-well plates were co-transfected with the TP1-luci-
ferase Notch reporter plasmid and a Renilla  luciferase
reporter (pRL-TK; Promega, Madison, WI) and empty vec-
tor using FuGENE 6 (Roche, Basel, Switzerland). At 16 h
post-transfection, ES cells were overlaid with 1 × 106
Jagged1-expressing L cells or Delta1-expressing L cells or
parental L cells. At ~40 h post-transfection, firefly and
Renilla luciferase activities were quantitated in cell lysates
using a dual luciferase assay kit (Promega, Madison, WI)
on Autolumat Plus LB 953 (Berthold Technologies, Bad
Wildbad, Germany) according to the manufacturer's
instructions. Ligand-dependent Notch activation is
expressed as fold-induction of normalized firefly luci-
ferase activity obtained from Notch ligand versus L cell co-
cultures. Co-culture assays with Notch1in32/in32  ES cells
(290-2) compared to Notch1+/+ ES cells (C1) were per-
formed by the same method in 12-well plates using Lipo-
fectamine (Invitrogen) for transfection of plasmids.
Whole Mount in situ Hybridization
Embryos of E8.75, E9.0 or E9.5 from Notch1+/lbd crosses
were harvested and DNA was prepared from yolk sac for
genotyping. Embryos for whole mount in situ hybridiza-
tion were fixed in 4% formaldehyde in PBS overnight at
4°C. Whole-mount in situ hybridization was performed as
previously described [16]. The hybridization probes used
were: Notch1 full length, ~9.5 kb or ~4.7 kb [44]; Uncx4.1
~1.7 kb [45], Hes5 ~1.3 kb [46]; and Myogenin ~1.5 kb
[47]. Stained embryos were photographed in PBS through
a phototube on Leica Wild M3Z stereomicroscope (Leica-
Microsystems, Heerburgg, Switzerland) using a Canon
S40 digital camera (Canon USA Inc., Lake Success, NY).
List of abbreviations
lbd: ligand binding domain; Pofut1: protein O-fucosyl-
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